OTLC 股價走勢圖
OTLC 收益
Oncotelic Therapeutics Inc
$0.03
5.56%
$0
收盤價：May 07, 16:00:00 GMT-4
$0.03
1.28%
$0
盤後：May 07, 20:00:00 GMT-4
返回
Oncotelic Therapeutics Inc (OTLC) 收益
關鍵數據
前收市價
$0.0367
開盤價
$0.038
當日範圍
$0.0376 - $0.0393
52週區間
$0.02 - $0.11
交易量
--
平均成交量
274.9K
股息收益率
--
每股盈餘 (TTM)
-0.00
市值
$17.3M
什麼是 OTLC？
Oncotelic Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. The company is headquartered in Agoura Hills, California and currently employs 26 full-time employees. The firm has three primary drugs and AI technology programs: AL-101 - Intranasal drug and delivery system for intra-nasal Apomorphine for the treatment of Parkinson’s Disease (PD), erectile dysfunction (ED) and female sexual dysfunction (FSD); CA4P- a vascular disrupting agent (VDA) - in combination with Ipilimumab for the treatment of solid tumors with focus on melanoma in adult and pediatric melanoma; Oxi4503- a second generation VDA - for the treatment of liquid tumors with focus on childhood leukemia; OT-101 - an antisense against TGF-b2-for the treatment of various cancers and for the treatment of various viruses, and Artemisinin-a natural derivative from an Asian herb Artemisia Annua.
